¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse cerebral sclerosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
¿µ¹® cerebral hemisphere ÇÑ±Û ´ë³ú¹Ý±¸
¼³¸í   
  ´ë³ú¶õ ³úÀÇ °¡Àå Å« ºÎºÐÀ» Â÷ÁöÇϴ °÷À¸·Î »ç°í, ¿îµ¿, ¼º°Ý, ±â¾ï µîÀÇ °íÂ÷¿øÀûÀΠ±â´ÉÀ» ÇàÇϴ °÷ÀÌ´Ù. ´ë³ú´Â Å©°Ô ÁÂ, ¿ì µÎ °³·Î ³ª´µ¾îÁ® ÀÖ°í °¢°¢À» ÁÂ, ¿ì ´ë³ú¹Ý±¸¶ó°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • disseminated sclerosis
    ÆÄÁ¾°æÈ­Áõ
  • endocardial sclerosis
    ½É³»¸·°æÈ­Áõ
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • funicular sclerosis
    ¼¶À¯´Ü°æÈ­
  • hippocampal sclerosis
    ÇØ¸¶°æÈ­(Áõ)
  • insular sclerosis
    ¼¶°æÈ­Áõ
  • lobar sclerosis
    ¿±¼º°æÈ­Áõ
  • multiple sclerosis
    ´Ù¹ß°æÈ­Áõ
  • medial calcific sclerosis
    Á߸·¼®È¸È­°æÈ­Áõ
  • nodular sclerosis
    °áÀý°æÈ­
  • nuclear sclerosis
    ¼öÁ¤Ã¼ÇÙ°æÈ­
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ, ô¼öÈÄ»è°æÈ­Áõ
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ, ¾Æ±Þ¼º¿¬ÇÕº¯¼º
  • presenile sclerosis
    ÃʷΰæÈ­Áõ
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ, ¿ø¹ßÃø»è°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • coronary sclerosis
    ½ÉÀ嵿¸Æ°æÈ­Áõ, °ü»óµ¿¸Æ°æÈ­Áõ
  • disseminated sclerosis
    (¢¡multiple sclerosis) ´Ù¹ß°æÈ­Áõ
  • endocardial sclerosis
    ½ÉÀå³»¸·°æÈ­Áõ
  • focal glomerular sclerosis
    ±¹¼ÒÅ丮±»À½Áõ, ±¹¼Ò»ç±¸Ã¼°æÈ­Áõ
  • funicular sclerosis
    ¼¶À¯´Ü°æÈ­(Áõ)
  • hippocampal sclerosis
    ÇØ¸¶°æÈ­Áõ
  • insular sclerosis
    (¢¡multiple sclerosis) ´Ù¹ß°æÈ­Áõ
  • lobar sclerosis
    ¿±°æÈ­Áõ
  • medial calcific sclerosis
    Á߸·¼®È¸È­°æÈ­Áõ
  • multiple sclerosis
    ´Ù¹ß°æÈ­Áõ
  • nodular sclerosis
    °áÀý°æÈ­Áõ
  • nuclear sclerosis
    ¼öÁ¤Ã¼ÇÙ°æÈ­
  • perigenital sclerosis
    »ý½Ä±âÁÖÀ§°æÈ­Áõ
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ
  • posterolateral sclerosis
    (¢¡subacute combined degeneration) ¾Æ±Þ¼º¿¬ÇÕº¯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hereditary spinal sclerosis
    À¯Àü¼º ô¼ö°æÈ­Áõ(¡­Ìãûùñø).
  • hodgkins disease,nodular sclerosis
    °áÀý¼º °æÈ­¼º
  • pigmentary sclerosis
    »ö¼Ò°æÈ­Áõ(ßäáÈàõ)
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ (¡­Ìãûùñø).
  • posterior spinal sclerosis
    ÈÄô¼ö°æÈ­Áõ(ý­ô±âÐÌãûùñø)
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ.
  • posterolateral sclerosis
    ÈÄ»èÃø»è°æÈ­Áõ(ÈÄ»èÃø»èÌãûùñø)
  • posterolateral sclerosis syndrome
    ÈÄ»èÃø»è°æÈ­ÁõÁõÈıº.
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ) (¡­Ìãûùñø).
  • presenile sclerosis
    Ãʷμº °æÈ­(Áõ)(ôøÖÕàõ Ìãûùñø)
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
  • primary posterolateral sclerosis
    ¿ø¹ß(¼º) ÈÄ¿ÜÃø»è°æÈ­(Áõ).
  • primary posterolateral sclerosis
    ¿ø¹ß(¼º) ÈÄ¿ÜÃø»è°æÈ­(Áõ)(ê«Û¡(àõ) ý­èâö°ßãÌãûù(ñø))
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º °£Áú¼º Æó·Å.
  • diffuse interstitial pulmonary disease
    ¹Ì¸¸¼º °£Áú¼º ÆóÁúȯ
  • diffuse interstitial pulmonary fibrosis
    ¹Ì¸¸¼º °£Áú¼º Æó¼¶À¯Áõ.
  • diffuse intravascular coagulation
    ¹ü¹ß¼º Ç÷°ü³»ÀÀ°í.
  • diffuse intravascular coagulopathy
    ¹ü¹ß¼º Ç÷°ü³» ÀÀ°íº´Áõ.
  • diffuse intravascular coagulopathy
    ¹Ì¸¸¼º ¹ü¹ß¼º Ç÷°ü³» ÀÀ°íº´Áõ.
  • diffuse labyrinthitis
    ¹Ì¸¸(¼º) ³»ÀÌ¿°, ¹Ì¸¸(¼º) ¹Ì·Î
  • diffuse nontoxic goiter
    ¹ü¹ß¼º ºñÁßµ¶¼º °©»ó¼±Á¾(¹ü¹ß¼ººñÁßµ¶¼º°©»ó¼±Á¾) .
  • diffuse nontoxic goiter
    ¹ü¹ß¼º ºñÁßµ¶¼º °©»ó¼±Á¾(ÛñÛ¡àõÞªñéÔ¸àõË£ßÒàÍðþ) .
  • diffuse pericementitis
    ¹Ì¸¸¼º Ä¡±Ù¸·¿°(¡­öÍÐÆØ¯æú).
  • diffuse peritonitis
    ¹Ì¸¸¼º º¹¸·¿°(¡­º¹¸·¿°).
  • diffuse peritonitis
    ¹Ì¸¸¼º º¹¸·¿°(¡­ÜÙØ¯æú).
  • diffuse placenta
    ÆÛÁøÅ¹Ý
  • diffuse reflection
    ¹Ì¸¸¼º ¹Ý»ç (گؼàõ ÚãÞÒ)
  • diffuse reflectors
    ¹Ì¸¸¼º ¹Ý»çü (گؼàõ ÚãÞÒô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
CPC central posterior curve; cerebellar Purkinje cell; cerebral palsy clinic; cerebral performance categ...
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
TCI total cerebral ischemia; transient cerebral ischemia; transcobalamin I
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DIB diffuse interstellar band
DIT Diffuse Intimal Thickening
DLBCL Diffuse Large B-cell Lymphoma
DLBD Diffuse Lewy body disease
DNIC diffuse noxious inhibitory control
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subchondral sclerosis
    ¿¬°ñÇÏ °æÈ­Áõ
  • subepithelial deposit and sclerosis
    »óÇÇÇÏ ÃàÀû°ú °æÈ­
  • systemic sclerosis
    Àü½Å¼º °æÈ­Áõ, °øÇÇÁõ. °æÇÇÁõ
    ÇǺÎ, ½ÉÀå, ½Äµµ, ½ÅÀå ¹× Æó¸¦ Æ÷ÇÔÇÑ ½Åü ¸ðµç ºÎÀ§ °áÇÕ Á¶Á÷ÀÇ ¸¸¼ºÀûÀÎ °æÈ­ ¹× À§Ãà. ÇǺδ ºñÈÄ, °æÈ­, °­Á÷µÇ°í Âø»öµÈ ¹ÝÀÌ »ý±ä´Ù. À̰ÍÀº Àü½Å¼ºÀÎ °æ¿ì »çÁöÀÇ ¸»´ÜºÎ³ª ¾ó±¼ ¶Ç´Â ¼Õ°¡¶ô¿¡ ±¹ÇÑµÈ °æ¿ì, EH´Â Á÷°æ ¼ö cmÀÇ l ³­Çü ¶Ç´Â ¼±»ó ¿µ¿ª¿¡ ±¹ÇÑ µÈ °æ¿ì°¡ ÀÖ´Ù.
  • tuberous sclerosis
    °áÀý¼º °æÈ­Áõ
    »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏ´Â º¹ÇÕÀûÀÎ ½Å°æ ÇǺΠÁõÈıºÀ¸·Î °£Áú, Á¤½Å ¹Ú¾à ¹× Ç÷°ü ¼¶À¯Á¾°ú »þ±×¸° ¹Ý
  • tuberous sclerosis
    °áÀý¼º °æÈ­Áõ
  • vascular sclerosis
    Ç÷°ü °æÈ­
  • acute cerebral anemia
    ±Þ¼º ³ú ºóÇ÷
  • anterior cerebral artery
    Àü´ë³úµ¿¸Æ
    ³»°æµ¿¸Æ¿¡¼­ ±â¿øÇϸç, ÇÇÁúÁö[¾È¿Í, ÀüµÎ, µÎÁ¤ºÎ], Àü¸Æ¶ô ÃÑÁö ¹× Áß½ÉÁö[³»Ãø¼±Á¶Ã¼µ¿¸ÆÀ» Æ÷ÇÔ], Àü±³±³Å뵿¸ÆÀÇ ºÐÁö¸¦ ³»¸ç, ¾È¿Í, ÀüµÎ¿±, µÎÁ¤¿±ÀÇ ÇÇÁú, ³ö·®, °£³ú, ¼±Á¶Ã¼ ³»Æ÷, Ãø³ú½ÇÀÇ ¸Æ¶ôÃÑ¿¡ ºÐÆ÷ÇÑ´Ù.
  • cerebral abscess
    ´ë³ú ³ó¾ç
    È­³ó¼º ¼¼±Õ¿¡ ÀÇÇÏ¿© ¹ß»ýÇÏ´Â ³úÀÇ ±¹¼ÒÀûÀÎ È­³ó¼º ±«»ç¼º º´º¯ÀÌ´Ù. ´ëºÎºÐÀÇ ÁßÃ߽Űæ°èÀÇ ¼¼±Õ¼º °¨¿°Àº ¼ö¸·¿°ÀÇ ÇüÅ·Π°¨¿°µÇ¾î ³ú ½ÇÁú³»·Î ÆÄ±ÞµÇ¸é ¼ö¸·³ú¿°À» ÀÏÀ¸Å°Áö¸¸ ¼ö¸·¿° ¾øÀÌ ³ú ½ÇÁúÀÌ Á÷Á¢ ¼¼±Õ¿¡ °¨¿°µÇ±âµµ Çϴµ¥ À̶§ ´ëºÎºÐ ³úÀÇ ÀϺο¡ ±¹ÇѵǴ ±¹¼ÒÀû ³ú¿°À» ÀÏÀ¸Å°¸ç ÀÌ º´º¯ÀÌ ÁøÇàµÇ¸é ³ú ³ó¾çÀ» Çü¼ºÇÏ°Ô µÈ´Ù. ±¹¼ÒÀûÀÎ ½Å°æ Áõ»óÀ» ÀÏÀ¸Å°´Â ¿Ü¿¡µµ ±× ÀÚü°¡ ÀÏÁ¾ÀÇ °ø°£ Á¡À¯¼º º´º¯ÀÌ°í ¶ÇÇÑ ºÎÁ¾À» µ¿¹ÝÇϹǷΠ±×¿¡ µû¸¥ ³ú¾Ð »ó½Â¿¡ ÀÇÇÑ Áõ»óÀÌ ³ªÅ¸³­´Ù. ½ÉÇÑ °æ¿ì¿¡´Â Ä¡¸íÀûÀÎ ³ú Å»ÃâÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù. ¶ÇÇÑ ³ó¾çÀÌ ÅÍÁö¸é ÅÍÁø ¹æÇâ¿¡ µû¶ó ³ú½Ç¿°, ¼ö¸·¿° ¹× Á¤¸Æµ¿ Ç÷ÀüÁõ µîÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù.
  • cerebral aneurysm
    ³ú µ¿¸Æ·ù
    ³ú µ¿¸ÆÀÇ ÀϺο¡ °á¼ÕÀÌ »ý°Ü ±× ºÎºÐÀÌ µ¹ÃâµÈ °Í. ¹æÃß»ó µ¿¸Æ·ù¿Í ³¶»ó µ¿¸Æ·ù°¡ ÀÖ´Ù. ÀüÀÚ´Â ³»°æ µ¿¸Æ, Ãß°ñ µ¿¸Æ, ³úÀú µ¿¸Æ µî¿¡¼­ º¼ ¼ö ÀÖ°í Ä¿Áö¸é ³ú Á¾¾ç°ú °°Àº ¾Ð¹Ú Áõ¼¼¸¦ ³ªÅ¸³»±âµµ ÇÑ´Ù. ÈÄÀÚ´Â ÆÄ¿­µÇ¾î ¸·ÇÏÃâÇ÷À» ÀÏÀ¸Å°¸ç Àü±³Åë µ¿¸Æ, ³»°æ µ¿¸Æ°ú Èı³Åë µ¿¸ÆÀÇ ±â½ÃºÎ, Áß´ë³úµ¿¸Æ ÈÄ´ë³úµ¿¸Æ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. ´ë³úµ¿¸Æ·û Àü¹ÝºÎ¿¡ ¾à 80 %°¡ Çü¼ºµÈ´Ù. ¿øÀÎÀº ¼±ÃµÀû ¿äÀÎÀ¸·Î »ý°¢µÈ´Ù. µ¿¸Æº®±ÙÃþÀÇ °á¿©, ³»Åº·Â¸·ÀÇ °á¼Õ µîÀÌ ÀÖÀ¸¸é, ±× ºÎÀ§´Â Ç÷·ù¿¡ ´ëÇÏ¿© ÀúÇ×ÀÌ ¾àÇØÁö°í È®ÀåµÇ¾î µ¿¸Æ·ù¸¦ Çü¼ºÇÑ´Ù. Ç÷°üº®ÀÇ ÀϺο¡ ¿°ÁõÀ̳ª °æÈ­¼º º´º¯ÀÌ »ý°Ü µ¿¸Æ·ù°¡ Çü¼ºµÇ±âµµ ÇÑ´Ù. µ¿¸Æ·ù´Â Ç÷°üº® ³»ÀÇ ÀûÀº ÃâÇ÷À» °ÅµìÇϸ鼭 Ä¿Áø´Ù. µ¿¸Æ·ù ±× ÀÚüÀÇ ¾Ð¹ÚÀ¸·Î µ¿¾È ½Å°æ ¸¶ºñ¸¦ ÀÏÀ¸Å°´Â °æ¿ìµµ ÀÖÁö¸¸, ´ëºÎºÐÀº Áõ¼¼°¡ ¾ø°í °©ÀÚ±â ÆÄ¿­µÇ¾î ÁöÁÖ¸·ÇÏ ÃâÇ÷À» ÀÏÀ¸Å²´Ù.
  • cerebral anoxia
    ³ú ¹«»ê¼ÒÁõ
  • cerebral aqueduct
    ´ë³ú ¼ö°ü, ´ë³ú ¼öµµ
  • cerebral arteriosclerosis
    ³ú µ¿¸Æ °æÈ­Áõ
  • cerebral atonic diplegia
    ³ú¼º À̿ϼº¾ç ¸¶ºñ
  • cerebral carotic artery
    ³ú °æµ¿¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nodular sclerosis <cardiology, pathology> The progressive narrowing and hardening of the arteries over time.
This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
nuclear sclerosis Increased refractivity of the central portion of the lens of the eye.
See: nuclear cataract.
(05 Mar 2000)
systemic sclerosis <rheumatology> A multisystem disorder of unknown aetiology. It is characterised by fibrosis (scarring) of the skin, blood vessels and internal organs. Involvement of the gastrointestinal tract, heart, kidneys and lungs is common.
(09 Jan 1998)
disseminated sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
idiopathic hypercalcaemic sclerosis of infants See: idiopathic hypercalcaemia of infants.
(05 Mar 2000)
insular sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
ovulational sclerosis A slowly progressive sclerosis in the walls of the ovarian arteries which commences after puberty.
Synonym: menstrual sclerosis, ovulational sclerosis.
(05 Mar 2000)
endocardial sclerosis <radiology> Unknown aetiology, diffuse thickening of endocardium, few live more than 2 yrs, limited to left chambers in 80%, causes restrictive cardiomyopathy
(12 Dec 1998)
tuberous sclerosis <radiology> (Bourneville disease) autosomal dominant phakomatosis classic triad: seizures, retardation, adenoma sebaceum, calcified subependymal hamartomas, uncalcified tubers in cerebral cortex, enhancing lesion most likely to be malignant transformation to giant cell astrocytoma associated with: skin lesions, angiomyolipoma, increased risk of renal cell carcinoma
(12 Dec 1998)
unicellular sclerosis A growth of fibrous tissue between and isolating the individual cells of a part.
(05 Mar 2000)
focal sclerosis <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain.
(18 Nov 1997)
focal sclerosis with hyalinosis <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome.
Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis.
(27 Sep 1997)
laminar cortical sclerosis A degeneration of nerve fibres in the corona radiata in a laminar pattern.
(05 Mar 2000)
lateral spinal sclerosis Considered by many to be a subgroup of motor neuron disease; a slowly progressive degenerative disorder of the motor neurons of the cerebral cortex, resulting in widespread weakness on an upper motor neuron basis; spasticity, hyperreflexia, and Babinski signs are present, but not fasciculation potentials, nor any electrodiagnostic evidence of a lower motor neuron lesion.
Synonym: lateral spinal sclerosis.
(05 Mar 2000)
lobar sclerosis Circumscribed atrophy of the cerebral cortex.
Synonym: lobar sclerosis, progressive circumscribed cerebral atrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á